35 related articles for article (PubMed ID: 38427187)
1. Structural separations by ion mobility-MS for glycomics and glycoproteomics.
Fenn LS; McLean JA
Methods Mol Biol; 2013; 951():171-94. PubMed ID: 23296531
[TBL] [Abstract][Full Text] [Related]
2. Pregnancy-associated serum N-glycome changes studied by high-throughput MALDI-TOF-MS.
Jansen BC; Bondt A; Reiding KR; Lonardi E; de Jong CJ; Falck D; Kammeijer GS; Dolhain RJ; Rombouts Y; Wuhrer M
Sci Rep; 2016 Apr; 6():23296. PubMed ID: 27075729
[TBL] [Abstract][Full Text] [Related]
3. Human Brain and Blood N-Glycome Profiling in Alzheimer's Disease and Alzheimer's Disease-Related Dementias.
Yu L; Huo Z; Yang J; Palma-Gudiel H; Boyle PA; Schneider JA; Bennett DA; Zhao J
Front Aging Neurosci; 2021; 13():765259. PubMed ID: 34776937
[TBL] [Abstract][Full Text] [Related]
4. MALDI Mass Spectrometry Imaging of N-Linked Glycans in Tissues.
Drake RR; West CA; Mehta AS; Angel PM
Adv Exp Med Biol; 2018; 1104():59-76. PubMed ID: 30484244
[TBL] [Abstract][Full Text] [Related]
5. CSF N-Glycomics Using MALDI MS Techniques.
Messina A; Romeo DA; Barone R; Sturiale L; Palmigiano A; Zappia M; Garozzo D
Methods Mol Biol; 2024; 2785():49-65. PubMed ID: 38427187
[TBL] [Abstract][Full Text] [Related]
6. CSF N-Glycomics Using MALDI MS Techniques in Alzheimer's Disease.
Palmigiano A; Messina A; Bua RO; Barone R; Sturiale L; Zappia M; Garozzo D
Methods Mol Biol; 2018; 1750():75-91. PubMed ID: 29512066
[TBL] [Abstract][Full Text] [Related]
7. Analysis of N- and O-linked glycans from glycoproteins using MALDI-TOF mass spectrometry.
Morelle W; Faid V; Chirat F; Michalski JC
Methods Mol Biol; 2009; 534():5-21. PubMed ID: 19277556
[TBL] [Abstract][Full Text] [Related]
8. CSF N-Glycoproteomics Using MALDI MS Techniques in Neurodegenerative Diseases.
Messina A; Palmigiano A; Bua RO; Romeo DA; Barone R; Sturiale L; Zappia M; Garozzo D
Methods Mol Biol; 2019; 2044():255-272. PubMed ID: 31432418
[TBL] [Abstract][Full Text] [Related]
9. Sensitive and robust MALDI-TOF-MS glycomics analysis enabled by Girard's reagent T on-target derivatization (GTOD) of reducing glycans.
Zhang Y; Wang B; Jin W; Wen Y; Nan L; Yang M; Liu R; Zhu Y; Wang C; Huang L; Song X; Wang Z
Anal Chim Acta; 2019 Feb; 1048():105-114. PubMed ID: 30598139
[TBL] [Abstract][Full Text] [Related]
10. Tear N-glycomics in vernal and atopic keratoconjunctivitis.
Messina A; Palmigiano A; Tosto C; Romeo DA; Sturiale L; Garozzo D; Leonardi A
Allergy; 2021 Aug; 76(8):2500-2509. PubMed ID: 33583051
[TBL] [Abstract][Full Text] [Related]
11. N-glycan and Alzheimer's disease.
Kizuka Y; Kitazume S; Taniguchi N
Biochim Biophys Acta Gen Subj; 2017 Oct; 1861(10):2447-2454. PubMed ID: 28465241
[TBL] [Abstract][Full Text] [Related]
12. Bisecting GlcNAc modification stabilizes BACE1 protein under oxidative stress conditions.
Kizuka Y; Nakano M; Kitazume S; Saito T; Saido TC; Taniguchi N
Biochem J; 2016 Jan; 473(1):21-30. PubMed ID: 26467158
[TBL] [Abstract][Full Text] [Related]
13. An aberrant sugar modification of BACE1 blocks its lysosomal targeting in Alzheimer's disease.
Kizuka Y; Kitazume S; Fujinawa R; Saito T; Iwata N; Saido TC; Nakano M; Yamaguchi Y; Hashimoto Y; Staufenbiel M; Hatsuta H; Murayama S; Manya H; Endo T; Taniguchi N
EMBO Mol Med; 2015 Feb; 7(2):175-89. PubMed ID: 25592972
[TBL] [Abstract][Full Text] [Related]
14. The role of protein glycosylation in Alzheimer disease.
Schedin-Weiss S; Winblad B; Tjernberg LO
FEBS J; 2014 Jan; 281(1):46-62. PubMed ID: 24279329
[TBL] [Abstract][Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
